Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?
Olema Pharmaceuticals Ownership Summary
Olema Pharmaceuticals is owned by 124.47% institutional investors, 3.21% insiders. Bain capital life sciences investors is the largest institutional shareholder, holding 13.05% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.19% of its assets in Olema Pharmaceuticals shares.
OLMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Olema Pharmaceuticals | 124.47% | 3.21% | -27.68% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 7.47M | 13.05% | $43.55M |
| Paradigm biocapital advisors lp | 7.30M | 12.76% | $42.59M |
| Bvf inc/il | 5.72M | 9.98% | $33.32M |
| Blackrock | 4.00M | 7.11% | $43.27M |
| Blackrock funding, inc. /de | 3.79M | 6.62% | $22.09M |
| Point72 asset management | 3.67M | 6.41% | $21.40M |
| Deep track capital, lp | 3.44M | 6.01% | $20.07M |
| Logos global management lp | 3.21M | 5.60% | $18.71M |
| Bioimpact capital | 2.91M | 5.09% | $16.98M |
| Vanguard group | 2.69M | 4.69% | $15.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 7.47M | 5.12% | $43.55M |
| Bioimpact capital | 2.91M | 2.41% | $16.98M |
| Logos global management lp | 3.21M | 2.19% | $18.71M |
| Ghost tree capital | 550.00K | 1.86% | $5.95M |
| Paradigm biocapital advisors lp | 7.30M | 1.48% | $42.59M |
| Bvf inc/il | 5.72M | 1.13% | $33.32M |
| Vivo capital | 1.51M | 0.98% | $8.78M |
| Deep track capital, lp | 3.44M | 0.75% | $20.07M |
| Highvista strategies | 212.19K | 0.46% | $1.24M |
| Boxer capital | 650.00K | 0.37% | $7.03M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bain capital life sciences investors | 7.47M | 5.12% | 7.47M |
| Paradigm biocapital advisors lp | 7.30M | 1.48% | 1.80M |
| Avoro capital advisors | 1.65M | 0.14% | 1.65M |
| Millennium management | 979.22K | 0.00% | 901.16K |
| Blackrock | 4.00M | 0.00% | 782.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | 5.72M | 1.13% | -3.42M |
| State street | 1.95M | 0.00% | -1.23M |
| Polar capital | - | - | -1.00M |
| Great point partners | - | - | -1.00M |
| Victory capital management | 93.10K | 0.00% | -758.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bain capital life sciences investors | 7.47M | 5.12% | 7.47M | $43.55M |
| Avoro capital advisors | 1.65M | 0.14% | 1.65M | $9.63M |
| Boxer capital | 650.00K | 0.37% | 650.00K | $7.03M |
| Pier capital | 272.37K | 0.23% | 272.37K | $1.59M |
| Bnp paribas arbitrage, snc | 193.75K | 0.00% | 193.75K | $1.13M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Abich financial wealth management | -10.00 |
| Lindbrook capital | -41.00 |
| Fortitude family office | -319.00 |
| Gamma investing | -321.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 158 | 17.04% | 71,277,656 | 21.51% | 124 | 1.19% | 91 | 35.82% | 38 | -7.32% |
| Sep 30, 2024 | 135 | 4.65% | 58,661,342 | 1.34% | 102 | 0.97% | 68 | -16.05% | 41 | 28.13% |
| Jun 30, 2024 | 129 | - | 57,887,400 | 3.20% | 102 | 1.01% | 81 | 15.71% | 32 | -3.03% |
| Mar 31, 2024 | 129 | 6.61% | 56,092,366 | 8.80% | 100 | 0.78% | 70 | -5.41% | 33 | 50.00% |
| Dec 31, 2023 | 121 | 15.24% | 51,555,296 | 9.00% | 113 | 1.03% | 74 | 37.04% | 22 | -26.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.63M | 2.19% | - |
| Vanguard US Total Market Shares ETF | 1.49M | 2.18% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.32M | 1.78% | - |
| iShares Russell 2000 ETF | 1.08M | 1.58% | -9.35K |
| Candriam Global Equities Oncology | 860.55K | 1.50% | 187.55K |
| Pictet-Biotech P USD | 946.99K | 1.39% | -1.75K |
| Franklin Small Cap Growth Adv | 893.20K | 1.20% | - |
| Pictet-Global Megatrend Sel I USD | 802.16K | 1.17% | 1.93K |
| SPDR® S&P Biotech ETF | 864.83K | 1.16% | -5.26K |
| Belfius Equities Cure C Cap | 850.45K | 1.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 08, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $1.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Buy | $4.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 17 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 8 |
| 2024 Q1 | - | 5 |
| 2023 Q4 | 4 | 23 |
OLMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools